CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Call for Patient Input and Clinical Experts: Entyvio

Published on: September 19, 2019
Result type: News

CADTH has received the following notice(s) of pending drug submission(s).

Brand name Entyvio
Generic name vedolizumab
Manufacturer Takeda Canada Inc.
Indication(s) Ulcerative Colitis
Project Number SR0635-000
Call for patient input 2019-09-19
Patient input deadline 2019-11-08
Submit patient input Submit
Register as Clinical Expert Register